 
|
|
Changes of the past, changes to come…
Biotechnology trends. In specific cases, the filling and packaging processes for these highly active, sometimes very expensive biopharmaceuticals require modified technologies. The in-process control developed by Optima Group Pharma in this context has led to substantial product savings and is also commonly applied in ‘conventional’ projects. [...]
Frame conditions. As machine manufacturers, we are convinced of the unchanging favorable development of the medium and long-term prospects for pharmaceutical filling and packaging machinery. In developed countries, the population is aging, so that medical care will become increasingly vital. [...]
New technologies. Disposable technologies still hold enormous potential. In this respect, Optima Group Pharma’s bet is on investing in developments for filling systems in-house. The partnership with Switzerland-based Lugaia STS was sealed with the acquisition of a company interest this year. Lugaia designed a certified and patented disposable process that supports sterile transfers into and out of isolator-protected zones. The approach uses pre-sterilized foils and specific welding technologies which produce peel-able compounds. [...]
Pharmaceutical machinery engineering in general is moving within a dynamic environment which can be successfully shaped only by those with extensive experience, technical creativity, and a maximum of responsibility.
Interested in the whole article? No problem. Just send an e-mail with the password „changes“ to info@optima-pharma.com |
back